Role of Vα 14 NKT Cells in the Development of Impaired Liver Regeneration In Vivo

Hepatology

Volumn 38, Issue 5, 2003, Pages 1116-1124

  Ito, Hiroyasu ^a   Ando, Kazuki ^a   Nakayama, Toshinori ^b   Taniguchi, Masaru ^b,c   Ezaki, Takayuki ^a   Saito, Kuniaki ^a   Takemura, Masao ^a   Sekikawa, Kenji ^d   Imawari, Michio ^e   Seishima, Mitsuru ^a   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c RIKEN   (Japan)

^d NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^e SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA GALACTOSYLCERAMIDE; GALACTOSYLCERAMIDE; INTERLEUKIN 12; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; GAMMA INTERFERON; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHRONIC HEPATITIS; IN VIVO STUDY; LIVER INJURY; LIVER REGENERATION; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; V ALPHA14 NATURAL KILLER CELL; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; GENETICS; KINETICS; LIVER; LIVER RESECTION; MALE; METABOLISM; METHODOLOGY; MONOCYTE; MOUSE MUTANT; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; POSTOPERATIVE PERIOD; T LYMPHOCYTE;

ANIMALS; CYTOKINES; GALACTOSYLCERAMIDES; HEPATECTOMY; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; KINETICS; LIVER; LIVER REGENERATION; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MONOCYTES; PHENOTYPE; POSTOPERATIVE PERIOD; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0142244910     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50471     Document Type: Article

References (35)

1. Trinchieri G. Interleukin 12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.
2. + T cells in various immune organs. J Immunol 1995;155:2972-2983.
3. + T lymphocytes, and NK cells. J Immunol 1992;149:3495-3502.
4. Gately M, Desai B, Wolitzky A, Quinn P, Dwyer C, Podlaski F, Familletti P, et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 1991;147:874-882.
5. Lentsch AB, Yoshidome H, Kato A, Warner RL, Cheadle WG, Ward PA, Edwards MJ. Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. HEPATOLOGY 1999;30:1448-1453.
6. Nicoletti F, Marco RD, Zaccone P, Salvaggio A, Magro G, Bendtzen K, Meroni P. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL- 12 through an interferon-γ dependent mechanism. HEPATOLOGY 2000;32:728-733.
7. Vingerhoets J, Michielsen P, Vanham G, Bosmans E, Paulij W, Ramon A, Pelckmans P, et al. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B. J Hepatol 1998;28:8-16.
8. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, Sasaki Y, et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 1999;162:5584-5591.
9. Matsushita T, Ando K, Kimura K, Ohnishi H, Imawari M, Muto Y, Moriwaki H. IL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo. Int Immunol 1999;11:657-665.
10. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997; 15:535-562.
11. Makino Y, Kanno R, Ito T, Higashino K, Taniguchi M. Predominant expression of invariant Vα 14+ TCRα chain in NK1.1+ T cell populations. Int Immuol 1995;7:1157-1161.
12. Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, et al. Requirement for Vα14 NKT Cells in IL-12-mediated rejection of tumors. Science 1997;278:1623-1626.
13. Taniguchi T, Tanaka M, Ikeda A, Momotani E, Sekikawa K. Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor α deficient mice. Lab Invest 1997;77:647-658.
14. Gately M, Warrier RR, Honasoge S, Carvajal DM, Faherty DA, Connaughton SE, Anderson TD, et al. Administration of recombinant IL-12 to normal mice enhances cycolytic lymphocyte activity and induces production of IFN-γ in vivo. Int Immunol 1994;6:157-167.
15. Ohteki T, Okuyama R, Seki S, Abo T, Sugiura K, Kusumi A, Ohmori T, et al. Age-dependent increase of extrathymic T cells in the liver and their appearance in the periphery of older mice. J Immunol 1992;149:1562-1570.
16. Trobonjaca Z, Lekhäuser F, Möller P, Schirmbeck R, Reimann J. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-γ release by liver NKT cells. J Immunol 2001; 167:1413-1422.
17. Higgins GM, Anderson RM. Experimental pathology of the liver: restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
18. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997;278:1626-1629.
19. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000; 192:921-930.
20. Osman Y, Kawamura T, Naito T, Takeda K, Kaer LV, Okumura K, Abo T. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur J Immunol 2000;30:1919-1928.
21. + T cells produce large amounts of IL-4 and IFN-g upon activation by Anti-CD3 of CD1. J Immunol 1997;159:2240-2249.
22. Matsuda LJ, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 2000;192:741-754.
23. Dieli F, Sireci G, Russo D, Taniguchi M, Ivanyi J, Fernandez C, Troye-Blomberg M, et al. Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J Exp Med 2000;192:1645-1651.
24. Ito K, Karasawa M, Kawano T, Akasaka T, Koseki H, Akutsu Y, Kondo E, et al. Involvement of decidual Va 14 NKT cells in abortion. Proc Natl Acad Sci U S A 2000;97:740-744.
25. Coutelier JP, Broeck JV, Wolf SF. Interleukin-12 gene expression after viral infection in the mouse. J Virol 1995;69:1955-1958.
26. Adachi K, Tsutsui H, Kashiwamura S, Seki E, Nakano H, Takeuchi O, Takeda K, et al. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J Immunol 2001;167:5928-5934.
27. Cavanaugh VJ, Guidotti LG, Chisari FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol 1997;71:3236-3249.
28. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996;4:25-36.
29. Wild J, Grusby MJ, Schirmbeck R, Reimann J. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T-cell dependent. J Immunol 1999;163:1880-1887.
30. Lasarte JJ, Corrales FJ, Casares N, Lopez-Diaz de Cerio A, Qian C, Xie X, Borrás-Cuesta F, et al. Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide. J Immunol 1999;162:5270-5277.
31. Gumperz JE, Roy C, Makowska A, Lum D, Sugita M, Podrebarac T, Koezuka Y, et al. Murine CD1d-restricted T-cell recognition of cellular lipids. Immunity 2000;12:211-221.
32. Kawamura T, Takeda K, Mendiratta SK, Kawamura H, Kaer LV, Yagita H, Abo T, et al. Critical role of NK1+ T cells in IL-12-induced immune responses in vivo. J Immunol 1998;160:16-19.
33. Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F, Nakayama T, et al. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 2000;191:105-114.
34. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997;94:1441-1446.
35. Yamada Y, Webber EM, Kirillova I, Peschon JJ, Fausto N. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. HEPATOLOGY 1998; 28:959-970.